Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Japan
Manufacturing
FDA issues Form 483s to Japanese, Indian drugmakers
Two Japanese drugmakers and another in India were hit with Form 483s from the FDA following inspections that uncovered a variety of problems.
Joseph Keenan
Sep 10, 2024 8:50am
Sanofi, DualityBio, UCB—Fierce Pharma Asia
Aug 30, 2024 8:05am
UPDATED: Astellas employee indicted by China’s prosecutors
Aug 21, 2024 11:10am
Kyowa Kirin trims small molecule research, Asian operations
Aug 1, 2024 2:06pm
Sumitomo Pharma weighs layoffs in Japan amid revenue dip: report
Jun 27, 2024 8:40am
Asahi Kasei moves to buy Calliditas for more than $1B
May 28, 2024 11:19am
